Literature DB >> 34035777

The Role of Small Molecule Inhibition of Leukocyte Trafficking in Inflammatory Bowel Disease.

Hugh Rosen1.   

Abstract

Entities:  

Year:  2021        PMID： 34035777      PMCID： PMC8132633     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.

Authors:  Julián Panés; Azucena Salas
Journal:  J Crohns Colitis       Date:  2018-08-22       Impact factor: 9.071

Review 2.  Strategies that target leukocyte traffic in inflammatory bowel diseases: recent developments.

Authors:  Jesús Rivera-Nieves
Journal:  Curr Opin Gastroenterol       Date:  2015-11       Impact factor: 3.287

3.  Ozanimod in Crohn's disease: a promising new player.

Authors:  Jasmijn A M Sleutjes; Annemarie C de Vries; C Janneke van der Woude
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-06-15

Review 4.  Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.

Authors:  K O Arseneau; F Cominelli
Journal:  Clin Pharmacol Ther       Date:  2014-12-02       Impact factor: 6.875

Review 5.  Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.

Authors:  Tamara Pérez-Jeldres; Christopher J Tyler; Joshua D Boyer; Thangaraj Karuppuchamy; Giorgos Bamias; Parambir S Dulai; Brigid S Boland; William J Sandborn; Derek R Patel; Jesús Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.